PrecivityAD blood test

Topic Status Complete

PrecivityAD blood test for the assessment of Alzheimer’s Disease

Summary

 

The PrecivityAD test is a blood-based biomarker assay intended for use in the diagnosis of Alzheimer’s disease. Health Technology Wales researchers searched for evidence on the effectiveness of the PrecivityAD test in the assessment, management or diagnosis of Alzheimer’s disease.

 

Based on the evidence identified, HTW’s Assessment Group concluded not to progress this topic to evidence appraisal.

Topic Exploration Report

TER557 11.2024